Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) CEO Faraz Ali sold 22,232 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $0.71, for a total transaction of $15,784.72. Following the sale, the chief executive officer directly owned 417,782 shares in the company, […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $515.03, for a total transaction of $4,892,785.00. Following the sale, the chief executive officer directly owned 324,443 shares of the company’s […]